Long-Term Care¶
The decade-and-beyond view of transfeminine health. HRT effects stabilize in the first 2–5 years; everything after that is maintenance — keeping hormone levels in target range, screening for the cancers that retained anatomy still produces, monitoring bone density and cardiovascular markers, and managing the ordinary aging process on top of a body shaped by estrogen.
This section is the deliberate continuation of the medical pillar past the acute-titration phase. If you started HRT five days ago, the HRT section is your home; come back here at year three. If you've been on HRT for a decade and want to understand what to monitor, or if you're 50 and wondering how the next 30 years play out, this is the right place.
Audience
This section assumes 2+ years post-transition. New patients should start with HRT and the surgery sections; the long-term content here will keep until you've cleared the acute window.
Subtopics¶
| Page | What it covers |
|---|---|
| The 5+ Year Trajectory | What stabilizes, what keeps changing; when re-titration matters |
| Cancer Screening | Prostate (retained), breast tissue, skin, peritoneal mucosa post-PPV — what to screen and when |
| Bone Health & DXA | Osteoporosis risk after orchi, DXA cadence, treatment thresholds |
| Cardiovascular Health | Lipids, BP, VTE, MI/stroke risk; oral vs transdermal at 40+ |
| Metabolic Health | Weight trajectory, T2DM screening, hepatic monitoring |
| Sexual Health Long-Term | Function over years, dyspareunia, atrophy management, libido on stable HRT |
| Fertility & Parenting Paths | Sperm cryo timing and yield, TESE backup, donor and adoption paths |
| HRT Continuity | Why HRT is lifelong, what discontinuation looks like, planning for cost/supply disruption |
| Aging on HRT | Soft tissue at 10/20/30 years, skin aging, late-life surgery candidacy |
| Affirming Primary Care | Vetting questions for ongoing PCP, building a long-term care team |
| Elder Care & End-of-Life Planning | Trans-affirming gerontology, advance directives, post-mortem documentation control |
How to use this section¶
- If you're at year 2–5, start with The 5+ Year Trajectory and skim the screening pages so you know what monitoring should be in place.
- If you've been stable for years, the screening and cardiovascular pages are the most consequential ongoing reads.
- If you're 40+, Cardiovascular Health and the HRT-route-switch logic deserve focused attention.
- If you're planning ahead, Elder Care and Fertility & Parenting Paths are the planning anchors.
What's not here¶
- Specific medical advice. Every recommendation here is general; your individual screening and monitoring schedule belongs to your PCP and endocrinologist.
- A substitute for primary care. This section helps you ask the right questions; it does not replace an actual care team.
- Surgical revision detail. Late-life revision considerations are noted here; the procedure-specific detail lives in the surgery sections.
Sources & further reading¶
- WPATH Standards of Care v8 — Chapter 16, Cancer
- Endocrine Society Guideline (Hembree et al. 2017) — long-term monitoring schedule
- Amsterdam ENIGI cohort publications — the primary long-term outcomes data source
- UCSF Center of Excellence for Transgender Health — Primary Care Protocols — the de facto US clinical reference
- See individual subpages for topic-specific source lists